Heart scarring detected more than a year after COVID-19 vaccination in some patients

When some people started experiencing myocarditis, or heart inflammation, after receiving COVID-19 vaccines, public health authorities and the media downplayed the severity of the problem and insisted that the protection offered by the vaccines was worth the risk. However, it is now emerging than the problem is more serious than vaccine supporters initially claimed.

A new study by Australian researchers revealed that one third of patients who suffered from myocarditis after getting a COVID-19 vaccine still had heart scarring more than a year later. This is according to cardiac imaging that showed persistent late gadolinium enhancement (LGE), which is typically an indicator of heart scarring.

In the study, the median time between the day the person received the vaccine and when they underwent follow-up imaging was 548 days; the longest interval among those studied was 603 days.

The researchers wrote: “We found that the incidence of persistent myocardial fibrosis is high, seen in almost a third of patients at >12 months post diagnosis, which could have implications for the management and prognosis of this predominantly young cohort.”

They cautioned that we do not yet know what the long-term clinical implications of this are. However, given the fact that LGE tends to indicate a worse prognosis in myocarditis that is not connected to COVID-19 vaccines, particularly when it persists longer than six months, there is plenty of reason to be concerned.

Most of the patients in the study had received the Pfizer vaccine, while some received jabs from Moderna or AstraZeneca....<<<Read More>>>...